- Home
- NAII vs XAIR Comparison
NAII vs XAIR Comparison
Compare NAII & XAIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NAII
- XAIR
- Stock Information
- Founded
- NAII 1980
- XAIR 2011
- Country
- NAII United States
- XAIR United States
- Employees
- NAII N/A
- XAIR N/A
- Industry
- NAII Medicinal Chemicals and Botanical Products
- XAIR Medical/Dental Instruments
- Sector
- NAII Health Care
- XAIR Health Care
- Exchange
- NAII Nasdaq
- XAIR Nasdaq
- Market Cap
- NAII 21.2M
- XAIR 17.0M
- IPO Year
- NAII 1987
- XAIR N/A
- Fundamental
- Price
- NAII $3.50
- XAIR $2.43
- Analyst Decision
- NAII
- XAIR Strong Buy
- Analyst Count
- NAII 0
- XAIR 1
- Target Price
- NAII N/A
- XAIR $11.00
- AVG Volume (30 Days)
- NAII 6.0K
- XAIR 8.8M
- Earning Date
- NAII 11-12-2025
- XAIR 11-10-2025
- Dividend Yield
- NAII N/A
- XAIR N/A
- EPS Growth
- NAII N/A
- XAIR N/A
- EPS
- NAII N/A
- XAIR N/A
- Revenue
- NAII $125,483,000.00
- XAIR $4,782,000.00
- Revenue This Year
- NAII N/A
- XAIR $265.24
- Revenue Next Year
- NAII N/A
- XAIR $136.17
- P/E Ratio
- NAII N/A
- XAIR N/A
- Revenue Growth
- NAII 4.39
- XAIR 168.20
- 52 Week Low
- NAII $2.57
- XAIR $2.02
- 52 Week High
- NAII $6.77
- XAIR $13.52
- Technical
- Relative Strength Index (RSI)
- NAII 45.26
- XAIR 48.32
- Support Level
- NAII $3.28
- XAIR $2.13
- Resistance Level
- NAII $3.87
- XAIR $4.78
- Average True Range (ATR)
- NAII 0.17
- XAIR 0.32
- MACD
- NAII -0.04
- XAIR 0.05
- Stochastic Oscillator
- NAII 31.88
- XAIR 11.82
About NAII Natural Alternatives International Inc.
Natural Alternatives International Inc is engaged in formulating, manufacturing, and marketing nutritional supplements. It offers vitamins, minerals, herbs, and other supplements, as well as other healthcare products to customers within the United States and internationally. Its business activity is operated through Private-Label Contract Manufacturing and Patent & Trademark Licensing segment. The company derives the majority of revenue from Private-Label Contract Manufacturing which is engaged in providing manufacturing services to companies that market and distribute nutritional supplements and other healthcare products, whereas the Patent and Trademark Licensing segment includes royalty income from its license and supply agreements associated with the sale.
About XAIR Beyond Air Inc.
Beyond Air Inc is a commercial-stage medical device and biopharmaceutical company that develops a Nitric Oxide (NO) Generator and Delivery System that uses NO generated from ambient air and delivers precise amounts of NO to the lungs for the potential treatment of respiratory and other diseases. The firm is applying its therapeutic expertise to develop treatments for pulmonary hypertension, in addition to treatments for lower respiratory tract infections.